These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3140309)

  • 1. [Detection of skin sensitivity in human brucellosis with a phenol-soluble antigen and the prevention of this disease using the phenol-insoluble fraction].
    Biron G; Bentejac MC; Ajjan N
    Rev Elev Med Vet Pays Trop; 1987; 40(4):365-7. PubMed ID: 3140309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a phenol-soluble Brucella antigen in man as a test to detect specific skin sensitivity].
    Bertrand A; Bentejac MC; Biron G; Siffert M; Bostvironnois C; Roumiantzeff M
    Dev Biol Stand; 1984; 56():547-51. PubMed ID: 6436112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human brucellosis vaccine obtained from the phenol-insoluble fraction of Brucella abortus strain B 19. Production, control, standardization].
    Desmettre P; Joubert L; Valette L; Roux J
    Dev Biol Stand; 1984; 56():579-86. PubMed ID: 6436115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological properties and chemical composition of a soluble fraction of Brucella abortus. Monospecific A or M antigens].
    Renoux G; Renoux M; Guillaumin JM
    Dev Biol Stand; 1976; 31():100-9. PubMed ID: 816680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucella abortus strain RB51 vaccine: its advantages and risks.
    Kahler SC
    J Am Vet Med Assoc; 1998 Jul; 213(1):12, 22. PubMed ID: 9656011
    [No Abstract]   [Full Text] [Related]  

  • 7. Human brucellosis: immunoblotting analysis of three Brucella abortus antigenic fractions allows the detection of components of diagnostic importance.
    Goldbaum FA; Morelli L; Wallach J; Rubbi CP; Fossati CA
    Medicina (B Aires); 1991; 51(3):227-32. PubMed ID: 1726568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunobiological properties of the protective brucellosis antigen].
    Dranovskaia EA; Vershilova PA; Grekova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):66-70. PubMed ID: 4216217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune response of guinea pigs to combined action of brucella vaccine and homologous lysed antigen].
    Rementsova MM; Shin NG; Usmanova FI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Mar; (3):72-5. PubMed ID: 6774529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brucellosis in the Waikato: some aspects concerning laboratory diagnosis.
    McKay EJ
    N Z Med J; 1972 Oct; 76(485):265-9. PubMed ID: 4630061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dot immunoassay with colloidal silver particles as a marker of specific antigen for testing human sera for brucellosis].
    Zagoskina TIu; Kalinovskiĭ AI; Merinov SP; Dokorina AA; Golubinskiĭ EP
    Med Parazitol (Mosk); 2002; (2):15-7. PubMed ID: 12214514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standardization on a laboratory animal of an intradermal test intended to detect human delayed brucellar hypersensitivity].
    Roumiantzeff M; Colombet G; Joubert L; Desmettre P
    Dev Biol Stand; 1984; 56():393-9. PubMed ID: 6436101
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin test reactions to a phenol-soluble antigen of Brucella abortus among veterinary students, Lyon, France, 1984.
    Duclos PJ; Bentejac MC; Serre A; Bascoul S
    Int J Epidemiol; 1989 Jun; 18(2):446-50. PubMed ID: 2767861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis.
    Dubray G; Bézard G
    Ann Rech Vet; 1980; 11(4):367-73. PubMed ID: 6802061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
    Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction, separation, and partial characterization of Brucella abortus antigens.
    Stone SS; Patterson JM; Deyoe BL
    Am J Vet Res; 1982 Jan; 43(1):149-53. PubMed ID: 6178324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of the protein antigens of Br. abortus and Yersinia enterocolitica type 9].
    Kostov G; Bozilov B; Todorova P; Todorov T
    Vet Med Nauki; 1980; 17(5):60-6. PubMed ID: 6165133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the diagnosis of brucellosis.
    Stemshorn BW
    Dev Biol Stand; 1984; 56():325-40. PubMed ID: 6436099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brucella vaccination in professionally exposed subjects. Prospective study].
    Strady A; Lienard M; Gillant JC; Barrat F; Poncelet S; Laudat P; Audurier A; Limet J; Ajjan N
    Presse Med; 1992 Sep; 21(30):1408-12. PubMed ID: 1454777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.